WINNIPEG, Manitoba — June 30, 2022 – Canadian biotech company Cytophage Technologies Inc. has been awarded $250,000 USD in non-dilutive funding to develop biological solutions for plant bacterial challenges at the Donald Danforth Plant Science Center in St. Louis, Missouri, the world’s largest independent plant science research institute.
The funding is provided by the Wells Fargo Innovation Incubator (IN2), a technology incubator and platform funded by the Wells Fargo Foundation and co-administered by the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL). Cytophage was selected to participate in the program with four other sustainable agriculture companies focused on using biological solutions to improve the resilience of global food systems.
“Our challenge is to generate unique solutions for emerging plant pathogens and build resiliency in our global food production systems. We are driving innovation to enhance food security and contribute to a safe and accessible food supply for people around the world,” says Dr. Steven Theriault, the CEO of Cytophage.
“With growing populations coupled with environmental shifts, farmers need technologies that will provide more yield using available resources ultra-efficiently and in the least harmful way,” said Trish Cozart, IN2 program manager at NREL. “Agriculture technologies that provide diversified supply, as well as resilience from disease, play a significant part in securing our future.”